1365 related articles for article (PubMed ID: 26073595)
21. Candidacy for a Subcutaneous Implantable Cardioverter Defibrillator in Patients with Cardiac Resynchronization Therapy.
Kawabata M; Goya M; Takahashi Y; Maeda S; Yagishita A; Shirai Y; Kaneko M; Shiohira S; Hirao K
Int Heart J; 2018 Sep; 59(5):951-958. PubMed ID: 30101850
[TBL] [Abstract][Full Text] [Related]
22. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
[TBL] [Abstract][Full Text] [Related]
23. Nontraditional surgical approaches for implantation of pacemaker and cardioverter defibrillator systems in patients with limited venous access.
Jaroszewski DE; Altemose GT; Scott LR; Srivasthan K; Devaleria PA; Lackey J; Arabia FA
Ann Thorac Surg; 2009 Jul; 88(1):112-6. PubMed ID: 19559206
[TBL] [Abstract][Full Text] [Related]
24. [The implantable cardioverter/defibrillator (ICD). Developments up to the present time and future perspectives].
Brachmann J; Hilbel T; Schöls W; Beyer T; Schweizer M; Sterns L; Karolyi L; Melichercik J; Freigang KD; Kübler W
Herz; 1994 Oct; 19(5):246-50. PubMed ID: 8001897
[TBL] [Abstract][Full Text] [Related]
25. Device interaction between cardiac contractility modulation (CCM) and subcutaneous defibrillator (S-ICD).
Trolese L; Faber T; Gressler A; Steinfurt J; Stuplich J; Jordan E; Bode C; Zehender M; Hilgendorf I
J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3095-3098. PubMed ID: 34379359
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.
Weiss R; Knight BP; Gold MR; Leon AR; Herre JM; Hood M; Rashtian M; Kremers M; Crozier I; Lee KL; Smith W; Burke MC
Circulation; 2013 Aug; 128(9):944-53. PubMed ID: 23979626
[TBL] [Abstract][Full Text] [Related]
27. Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results.
Gold MR; Aasbo JD; El-Chami MF; Niebauer M; Herre J; Prutkin JM; Knight BP; Kutalek S; Hsu K; Weiss R; Bass E; Husby M; Stivland TM; Burke MC
Heart Rhythm; 2017 Oct; 14(10):1456-1463. PubMed ID: 28502872
[TBL] [Abstract][Full Text] [Related]
28. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
[TBL] [Abstract][Full Text] [Related]
29. Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers.
Geiger MJ; O'Neill P; Sharma A; Skadsen A; Zimerman L; Greenfield RA; Newby KH; Wharton JM; Kent V; Natale A
Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 1):624-30. PubMed ID: 9080488
[TBL] [Abstract][Full Text] [Related]
30. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].
Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R
Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168
[TBL] [Abstract][Full Text] [Related]
31. Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey.
Boveda S; Lenarczyk R; Fumagalli S; Tilz R; Goscinska-Bis K; Kempa M; Defaye P; Marquié C; Capucci A; Ueberham L; Dagres N
Europace; 2018 May; 20(5):887-892. PubMed ID: 29432525
[TBL] [Abstract][Full Text] [Related]
32. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
[TBL] [Abstract][Full Text] [Related]
33. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.
Knops RE; Olde Nordkamp LR; de Groot JR; Wilde AA
Heart Rhythm; 2013 Aug; 10(8):1240-3. PubMed ID: 23707489
[TBL] [Abstract][Full Text] [Related]
34. Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction.
Boersma L; Burke MC; Neuzil P; Lambiase P; Friehling T; Theuns DA; Garcia F; Carter N; Stivland T; Weiss R;
Heart Rhythm; 2016 Jan; 13(1):157-64. PubMed ID: 26341604
[TBL] [Abstract][Full Text] [Related]
35. A completely subcutaneous implantable cardioverter defibrillator system functioning simultaneously with an endocardial implantable cardioverter defibrillator programmed as pacemaker.
van Opstal J; Geskes G; Debie L
Europace; 2011 Jan; 13(1):141-2. PubMed ID: 20587539
[TBL] [Abstract][Full Text] [Related]
36. Cardiac Implantable Electronic Device Therapy: Permanent Pacemakers, Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Devices.
Steffen MM; Osborn JS; Cutler MJ
Med Clin North Am; 2019 Sep; 103(5):931-943. PubMed ID: 31378335
[TBL] [Abstract][Full Text] [Related]
37. Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy.
Kühlkamp V;
J Am Coll Cardiol; 2002 Mar; 39(5):790-7. PubMed ID: 11869843
[TBL] [Abstract][Full Text] [Related]
38. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
[TBL] [Abstract][Full Text] [Related]
39. Clinical experience of combined HeartWare ventricular assist device and implantable cardioverter defibrillator therapy.
Pecha S; Wilke I; Bernhardt A; Hakmi S; Yildirim Y; Steven D; Reichenspurner H; Willems S; Deuse T; Aydin A
J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1109-14. PubMed ID: 24862733
[TBL] [Abstract][Full Text] [Related]
40. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
